Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: an open clinical trial

被引:31
|
作者
Zielinsky, P. [1 ]
Piccoli, A. L., Jr. [1 ]
Manica, J. L. L. [1 ]
Nicoloso, L. H. [1 ]
Vian, I. [1 ]
Bender, L. [1 ]
Pizzato, P. [1 ]
Pizzato, M. [1 ]
Swarowsky, F. [1 ]
Barbisan, C. [1 ]
Mello, A. [1 ]
Garcia, S. C. [1 ]
机构
[1] FUC IC FUC, Inst Cardiol Rio Grande Sul, Fetal Cardiol Unit, Porto Alegre, RS, Brazil
关键词
fetal ductal constriction; prostaglandins; pulmonary hypertension; polyphenol-rich foods; PERSISTENT PULMONARY-HYPERTENSION; PREMATURE CLOSURE; GREEN TEA; ARTERIOSUS; INDOMETHACIN; ANTIOXIDANT; CONSUMPTION; INGESTION; THEAFLAVIN; EXTRACT;
D O I
10.1038/jp.2011.153
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To test the hypothesis that maternal restriction of polyphenol-rich foods (PRF), which, like non-steroidal anti-inflammatory drugs (NSAID), inhibit prostaglandin synthesis in the third trimester, reverse fetal ductal constriction (DC). Study Design: An open clinical trial of 51 third trimester fetuses with DC with no history of NSAID intake was designed. All mothers were submitted to a food frequency questionnaire and were oriented to withdrawl PRF, being reassessed after 3 weeks. Doppler parameters were assessed before and after discontinuation of these substances. A control group of 26 third trimester normal fetuses, with no ductus arteriosus (DA) constriction, in which no dietary intervention was offered, was reviewed after 3 weeks. Student's t-test and Wilcoxon's test were used. Result: Mean gestational age was 32 +/- 3 weeks (28 to 37 weeks). After discontinuation of PRF (>= 3 weeks), 48/51 fetuses (96%) showed complete reversal of DC, with decrease in mean ductal systolic velocity (1.74 +/- 0.20 ms(-1) to 1.31 +/- 0.34 ms(-1), P < 0.001), mean diastolic velocity (0.33 +/- 0.09 ms(-1) to 0.21 +/- 0.07 ms(-1), P < 0.001) and mean right to left ventricular dimension ratio (1.37 +/- 0.26 to 1.12 +/- 0.17, P < 0.001) and increase in mean ductal pulsatility index (PI) (1.98 +/- 0.36 to 2.46 +/- 0.23, P < 0.001). Median daily maternal consumption of PRF was 286 mg per day and decreased after orientation to 0mg per day, P < 0.001. In the control group, with GA of 32 +/- 4 w (29-37 w), there was no significant differences in median daily maternal consumption of PRF, mean ductal systolic velocitiy, diastolic velocity, PI and right ventricular to left ventricular diameter ratio (RV/LV) ratio. Conclusion: Reduction of maternal PRF intake during pregnancy, especially in the third trimester, is followed by complete reversal of DC (wide open DA), which may influence maternal dietary habits in late pregnancy. Journal of Perinatology (2012) 32, 574-579; doi: 10.1038/jp.2011.153; published online 3 November 2011
引用
收藏
页码:574 / 579
页数:6
相关论文
共 41 条
  • [21] Crosstalk among intestinal barrier, gut microbiota and serum metabolome after a polyphenol-rich diet in older subjects with "leaky gut": The MaPLE trial
    Peron, Gregorio
    Gargari, Giorgio
    Merono, Tomas
    Minarro, Antonio
    Lozano, Esteban Vegas
    Escuder, Pol Castellano
    Gonzalez-Dominguez, Raul
    Hidalgo-Liberona, Nicole
    Del Bo, Cristian
    Bernardi, Stefano
    Kroon, Paul Antony
    Carrieri, Barbara
    Cherubini, Antonio
    Riso, Patrizia
    Guglielmetti, Simone
    Andres-Lacueva, Cristina
    CLINICAL NUTRITION, 2021, 40 (10) : 5288 - 5297
  • [22] Maternal low molecular weight heparin versus sildenafil citrate for fetal growth restriction: a randomized, parallel groups, open-label clinical trial
    Rasheedy, R.
    El Bishry, G.
    Tarek, R.
    JOURNAL OF PERINATOLOGY, 2020, 40 (05) : 715 - 723
  • [23] Maternal low molecular weight heparin versus sildenafil citrate for fetal growth restriction: a randomized, parallel groups, open-label clinical trial
    R. Rasheedy
    G. El Bishry
    R. Tarek
    Journal of Perinatology, 2020, 40 : 715 - 723
  • [24] Differential effect of polyphenol-rich dark chocolate on biomarkers of glucose metabolism and cardiovascular risk factors in healthy, overweight and obese subjects: a randomized clinical trial
    Almoosawi, S.
    Tsang, C.
    Ostertag, L. M.
    Fyfe, L.
    Al-Dujaili, E. A. S.
    FOOD & FUNCTION, 2012, 3 (10) : 1035 - 1043
  • [25] Effect of polyphenol-rich extra-virgin olive oil on lipid profile and inflammatory biomarkers in patients undergoing coronary angiography: a randomised, controlled, clinical trial
    Khandouzi, Nafiseh
    Zahedmehr, Ali
    Nasrollahzadeh, Javad
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2021, 72 (04) : 548 - 558
  • [26] Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction A Randomized Clinical Trial
    Pels, Anouk
    Derks, Jan
    Elvan-Taspinar, Ayten
    van Drongelen, Joris
    de Boer, Marjon
    Duvekot, Hans
    van Laar, Judith
    van Eyck, Jim
    Al-Nasiry, Salwan
    Sueters, Marieke
    Post, Marinka
    Onland, Wes
    van Wassenaer-Leemhuis, Aleid
    Naaktgeboren, Christiana
    Jakobsen, Janus C.
    Gluud, Christian
    Duijnhoven, Ruben G.
    Lely, Titia
    Gordijn, Sanne
    Ganzevoort, Wessel
    JAMA NETWORK OPEN, 2020, 3 (06)
  • [27] Sleep Apnea and Fetal Growth Restriction (SAFER) study: protocol for a pragmatic randomised clinical trial of positive airway pressure as an antenatal therapy for fetal growth restriction in maternal obstructive sleep apnoea
    Hincker, Alex
    Nadler, Jacob
    Karan, Suzanne
    Carter, Ebony
    Porat, Shay
    Warner, Barbara
    Ju, Yo-El S.
    Ben Abdallah, Arbi
    Wilson, Elizabeth
    Lockhart, Ellen M.
    Ginosar, Yehuda
    BMJ OPEN, 2021, 11 (06):
  • [28] Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Arcusa, Raul
    Angel Carillo, Juan
    Cerda, Begona
    Durand, Thierry
    Gil-Izquierdo, Angel
    Medina, Sonia
    Galano, Jean-Marie
    Pilar Zafrilla, Maria
    Marhuenda, Javier
    ANTIOXIDANTS, 2023, 12 (03)
  • [29] Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction
    Sheppard, M.
    Spencer, R. N.
    Ashcroft, R.
    David, A. L.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (04) : 484 - 491
  • [30] Differential effect of polyphenol-rich dark chocolate on biomarkers of glucose metabolism and cardiovascular risk factors in healthy, overweight and obese subjects: a randomized clinical trial (vol 3, pg 1035, 2012)
    Almoosawi, S.
    Tsang, C.
    Ostertag, L. M.
    Fyfe, L.
    Al-Dujaili, E. A. S.
    FOOD & FUNCTION, 2012, 3 (12) : 1324 - 1324